Clarivate (CLVT) Financials

$4.16 +0.08 (+1.96%)

Closing price 03:59 PM Eastern

Extended Trading

$4.12 -0.04 (-0.84%)

As of 05:38 PM Eastern

Annual Income Statements for Clarivate

This table shows Clarivate's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Net Income / (Loss) Attributable to Common Shareholders	-668	-987	-4,036	-312	-351	-259	-242	-264
Consolidated Net Income / (Loss)	-637	-911	-3,960	-271	-351	-259	-242	-264
Net Income / (Loss) Continuing Operations	-637	-911	-3,960	-271	-351	-259	-242	-264
Total Pre-Tax Income	-554	-1,013	-3,989	-258	-353	-248	-237	-285
Total Operating Income	-276	-735	-3,926	-87	-36	-82	-106	-147
Total Gross Profit	1,688	1,722	1,706	1,251	815	622	538	523
Total Revenue	2,557	2,629	2,660	1,877	1,254	974	968	918
Operating Revenue	2,557	2,629	2,660	1,877	1,254	974	968	918
Total Cost of Revenue	869	906	954	626	439	352	430	394
Operating Cost of Revenue	869	906	954	626	439	352	430	394
Total Operating Expenses	1,963	2,457	5,631	1,338	852	705	644	670
Selling, General & Admin Expense	728	740	730	643	545	475	413	343
Depreciation Expense	727	708	711	538	303	9.18	9.42	7.00
Other Operating Expenses / (Income)	-52	-11	-325	28	-52	-4.83	-6.38	2.48
Impairment Charge	560	1,020	4,516	130	0.00	18	0.00	0.00
Total Other Income / (Expense), net	-278	-278	-64	-171	-317	-166	-131	-138
Interest & Investment Income	-283	-294	-270	-	-	-	-	-
Other Income / (Expense), net	5.20	16	207	81	-205	-8.26	0.00	-
Income Tax Expense	83	-101	-29	12	-2.70	10	5.65	-21
Preferred Stock Dividends Declared	31	75	75	42	0.00	0.00	-	-
Basic Earnings per Share	($0.96)	($1.47)	($5.97)	($0.49)	($0.82)	($0.94)	($1.11)	($1.22)
Weighted Average Basic Shares Outstanding	693.60M	671.60M	676.10M	631M	427M	273.88M	217.47M	216.85M
Diluted Earnings per Share	($0.96)	($1.47)	($6.24)	($0.61)	($0.82)	($0.94)	($1.11)	($1.22)
Weighted Average Diluted Shares Outstanding	693.60M	671.60M	678.60M	640.80M	427M	273.88M	217.47M	216.85M
Weighted Average Basic & Diluted Shares Outstanding	691.64M	666.29M	674.43M	683.15M	427.02M	273.88M	217.47M	216.85M

This table shows Clarivate's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-104	-192	-66	-317	-94	-863	-6.60	-142	25	304	-4,434
Consolidated Net Income / (Loss)	-104	-192	-66	-304	-75	-844	12	-123	44	323	-4,416
Net Income / (Loss) Continuing Operations	-104	-192	-66	-304	-75	-844	12	-123	44	323	-4,416
Total Pre-Tax Income	-85	-132	-51	-311	-60	-862	28	-158	-20	246	-4,393
Total Operating Income	-21	-62	22	-240	5.00	-788	87	-88	55	319	-4,375
Total Gross Profit	387	435	412	437	403	452	427	445	399	438	412
Total Revenue	594	663	622	650	621	684	647	669	629	675	636
Operating Revenue	594	663	622	650	621	684	647	669	629	675	636
Total Cost of Revenue	207	228	210	214	218	232	221	224	230	237	224
Operating Cost of Revenue	207	228	210	214	218	232	221	224	230	237	224
Total Operating Expenses	408	498	390	677	398	1,240	339	533	345	120	4,787
Selling, General & Admin Expense	178	181	170	185	192	180	172	193	195	181	170
Depreciation Expense	185	186	177	184	179	181	177	178	173	189	170
Other Operating Expenses / (Income)	19	-99	26	3.60	18	20	-13	15	-32	-260	-27
Impairment Charge	25	230	18	304	9.50	859	3.70	147	9.40	67	4,449
Total Other Income / (Expense), net	-64	-70	-72	-71	-65	-74	-59	-70	-75	-73	-18
Interest & Investment Income	-64	-70	-72	-71	-70	-75	-72	-73	-74	-	-
Other Income / (Expense), net	0.00	-	0.00	0.00	5.20	1.50	13	2.90	-1.10	4.10	53
Income Tax Expense	19	60	15	-6.80	15	-18	16	-35	-64	-78	22
Preferred Stock Dividends Declared	0.00	-	0.00	13	19	19	19	19	19	19	19
Basic Earnings per Share	($0.15)	($0.27)	($0.09)	($0.46)	($0.14)	($1.29)	($0.01)	($0.21)	$0.04	$0.48	($6.58)
Weighted Average Basic Shares Outstanding	689.80M	693.60M	718.70M	685.60M	666.90M	671.60M	670.90M	675.90M	674.80M	676.10M	673.60M
Diluted Earnings per Share	($0.15)	($0.27)	($0.09)	($0.46)	($0.14)	($1.29)	($0.01)	($0.21)	$0.04	$0.46	($6.64)
Weighted Average Diluted Shares Outstanding	689.80M	693.60M	718.70M	685.60M	666.90M	671.60M	670.90M	675.90M	679.30M	678.60M	675.20M
Weighted Average Basic & Diluted Shares Outstanding	683.09M	691.64M	710.40M	724.14M	668.24M	666.29M	663.92M	676.23M	675.76M	674.43M	674.19M

This table details how cash moves in and out of Clarivate's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Net Change in Cash & Equivalents	-76	14	-231	315	196	51	-52	-7.47
Net Cash From Operating Activities	647	744	509	324	264	118	-26	6.67
Net Cash From Continuing Operating Activities	647	744	509	324	264	118	-26	6.67
Net Income / (Loss) Continuing Operations	-637	-911	-3,960	-271	-351	-259	-242	-264
Consolidated Net Income / (Loss)	-637	-911	-3,960	-271	-351	-259	-242	-264
Depreciation Expense	727	708	711	538	303	201	237	228
Amortization Expense	16	18	16	13	-	-	-	-
Non-Cash Adjustments To Reconcile Net Income	565	1,060	4,059	-25	204	172	6.04	14
Changes in Operating Assets and Liabilities, net	-25	-131	-317	68	107	3.72	-27	28
Net Cash From Investing Activities	-237	-237	57	-4,045	-2,989	-141	12	-40
Net Cash From Continuing Investing Activities	-237	-237	57	-4,045	-2,989	-141	12	-40
Purchase of Property, Plant & Equipment	-289	-243	-203	-119	-108	-70	-45	-38
Acquisitions	-32	-5.40	-25	-3,930	-2,923	-71	-24	-7.40
Divestitures	84	11	285	4.30	41	0.00	81	5.00
Net Cash From Financing Activities	-470	-497	-759	4,032	2,927	75	-33	23
Net Cash From Continuing Financing Activities	-470	-497	-759	4,032	2,927	75	-33	23
Repayment of Debt	-217	-301	-494	-61	-176	-2,076	-77	-16
Repurchase of Common Equity	-200	-100	-175	-159	0.00	-200	-	-
Payment of Dividends	-38	-76	-75	-19	0.00	0.00	-	-
Other Financing Activities, net	-16	-21	-15	-6.30	239	681	-0.90	9.06
Effect of Exchange Rate Changes	-15	3.60	-38	3.70	-5.00	-0.97	-5.19	3.25
Cash Interest Paid	265	274	252	182	98	101	122	115
Cash Income Taxes Paid	53	43	64	34	28	29	13	15

This table details how cash moves in and out of Clarivate's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	59	-93	12	-4.60	10	-37	-36	69	18	-100	84
Net Cash From Operating Activities	171	141	203	126	176	191	163	162	228	137	208
Net Cash From Continuing Operating Activities	171	141	203	126	176	191	163	162	228	137	208
Net Income / (Loss) Continuing Operations	-104	-192	-66	-304	-75	-844	12	-123	44	323	-4,416
Consolidated Net Income / (Loss)	-104	-192	-66	-304	-75	-844	12	-123	44	323	-4,416
Depreciation Expense	185	186	177	184	179	181	177	178	173	189	170
Amortization Expense	2.90	5.30	3.20	3.20	4.70	5.30	3.80	4.00	5.10	5.00	3.80
Non-Cash Adjustments To Reconcile Net Income	32	194	46	300	25	922	7.60	129	1.00	-222	4,419
Changes in Operating Assets and Liabilities, net	55	-52	42	-57	42	-73	-37	-26	5.30	-158	31
Net Cash From Investing Activities	-61	21	-92	-102	-64	-67	-63	-47	-60	228	-67
Net Cash From Continuing Investing Activities	-61	21	-92	-102	-64	-67	-63	-47	-60	228	-67
Purchase of Property, Plant & Equipment	-61	-82	-77	-66	-64	-64	-62	-58	-59	-46	-67
Net Cash From Financing Activities	-57	-240	-110	-26	-95	-174	-124	-46	-152	-492	-28
Net Cash From Continuing Financing Activities	-56	-240	-110	-26	-95	-174	-124	-46	-152	-492	-28
Repayment of Debt	0.00	-138	-5.70	-5.50	-68	-150	-0.30	-25	-125	-469	-7.70
Repurchase of Common Equity	-50	-100	-	-	-	-	-	-	-	-	-
Payment of Dividends	0.00	-	-	-19	-19	-19	-19	-19	-19	-19	-19
Other Financing Activities, net	-6.40	-1.70	-4.00	-1.30	-8.60	-5.80	-5.10	-2.20	-7.50	-1.90	-2.80
Effect of Exchange Rate Changes	5.10	-16	10	-3.00	-6.30	14	-12	-0.30	2.00	26	-28

This table presents Clarivate's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Assets	11,490	12,707	13,945	20,183	14,791	3,791	3,710
Total Current Assets	1,245	1,462	1,395	1,637	1,148	493	409
Cash & Equivalents	295	371	357	431	258	76	26
Accounts Receivable	798	908	872	906	738	334	331
Prepaid Expenses	86	89	89	77	58	41	31
Other Current Assets	65	68	77	67	79	42	21
Other Current Nonoperating Assets	0.00	27	0.00	-	-	-	-
Plant, Property, & Equipment, net	54	52	55	84	36	18	21
Total Noncurrent Assets	10,192	11,193	12,495	18,462	13,607	3,298	3,301
Goodwill	1,567	2,024	2,877	7,905	6,043	1,328	1,283
Intangible Assets	8,441	9,007	9,438	10,392	7,370	1,829	1,959
Noncurrent Deferred & Refundable Income Taxes	49	47	24	28	30	19	12
Other Noncurrent Operating Assets	136	116	157	137	164	104	27
Total Liabilities & Shareholders' Equity	11,490	12,707	13,945	20,183	14,791	3,791	3,710
Total Liabilities	6,351	6,715	7,132	8,257	5,756	2,543	2,659
Total Current Liabilities	1,434	1,600	1,560	1,902	1,423	651	644
Accounts Payable	125	144	101	129	82	26	38
Accrued Expenses	310	315	353	529	570	159	-
Current Deferred Revenue	859	983	948	1,030	707	407	391
Current Employee Benefit Liabilities	119	127	132	151	-	-	-
Other Current Liabilities	21	24	26	32	35	22	154
Other Current Nonoperating Liabilities	0.00	6.70	0.00	-	0.00	27	0.00
Total Noncurrent Liabilities	4,918	5,115	5,573	6,355	4,333	1,892	2,015
Long-Term Debt	4,519	4,721	5,005	5,456	3,458	1,629	1,930
Noncurrent Deferred Revenue	17	39	39	54	41	20	17
Noncurrent Deferred & Payable Income Tax Liabilities	273	250	316	380	367	49	43
Other Noncurrent Operating Liabilities	109	105	213	465	467	195	25
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,139	5,992	6,813	11,926	9,035	1,249	1,051
Total Preferred & Common Equity	5,139	5,992	6,813	11,926	9,035	1,249	1,051
Preferred Stock	0.00	1,393	1,393	1,393	0.00	-	-
Total Common Equity	5,139	4,600	5,420	10,533	9,035	1,249	1,051
Common Stock	12,979	11,741	11,745	11,828	9,989	2,144	1,678
Retained Earnings	-7,314	-6,646	-5,659	-1,604	-1,251	-891	-632
Accumulated Other Comprehensive Income / (Loss)	-526	-495	-666	327	492	-4.88	5.36

This table presents Clarivate's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	11,493	12,031	12,078	12,505	13,418	13,706	13,940	13,749
Total Current Assets	1,354	1,339	1,335	1,391	1,375	1,418	1,451	1,452
Cash & Equivalents	354	389	376	362	399	436	364	446
Accounts Receivable	831	772	796	823	767	770	839	749
Prepaid Expenses	101	98	87	100	100	102	111	99
Other Current Assets	69	81	75	68	75	77	127	150
Plant, Property, & Equipment, net	55	47	46	49	50	51	52	57
Total Noncurrent Assets	10,083	10,644	10,697	11,065	11,994	12,237	12,436	12,240
Goodwill	1,567	1,737	1,737	2,023	2,865	2,896	2,892	2,804
Intangible Assets	8,341	8,727	8,771	8,874	8,955	9,186	9,397	9,249
Noncurrent Deferred & Refundable Income Taxes	49	51	49	47	26	27	25	24
Other Noncurrent Operating Assets	127	130	140	121	147	129	123	163
Total Liabilities & Shareholders' Equity	11,493	12,031	12,078	12,505	13,418	13,706	13,940	13,749
Total Liabilities	6,466	6,517	6,473	6,616	6,736	6,767	6,980	7,674
Total Current Liabilities	1,541	1,526	1,485	1,615	1,469	1,498	1,610	1,633
Accounts Payable	120	127	128	103	99	108	102	106
Accrued Expenses	333	375	314	365	347	317	362	417
Current Deferred Revenue	979	890	912	1,010	889	940	1,040	858
Current Employee Benefit Liabilities	88	112	107	86	103	101	80	108
Other Current Liabilities	21	22	23	24	24	24	25	29
Total Noncurrent Liabilities	4,925	4,992	4,988	5,002	5,267	5,269	5,371	6,042
Long-Term Debt	4,521	4,633	4,635	4,638	4,866	4,863	4,885	5,417
Noncurrent Deferred & Payable Income Tax Liabilities	276	227	229	246	256	262	314	351
Other Noncurrent Operating Liabilities	128	110	100	100	109	106	134	236
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,027	5,514	5,605	5,888	6,682	6,938	6,959	6,075
Total Preferred & Common Equity	5,027	5,514	5,605	5,888	6,682	6,938	6,959	6,075
Total Common Equity	5,027	5,514	5,605	4,496	5,290	5,546	5,567	4,682
Common Stock	12,935	13,069	13,158	11,747	11,730	11,809	11,778	11,718
Retained Earnings	-7,417	-7,122	-7,056	-6,739	-5,783	-5,776	-5,634	-5,955
Accumulated Other Comprehensive Income / (Loss)	-491	-434	-497	-512	-658	-488	-578	-1,070

This table displays calculated financial ratios and metrics derived from Clarivate's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	-2.74%	-1.17%	41.71%	49.66%	28.71%	0.61%	5.54%	0.00%
EBITDA Growth	6,042.86%	100.26%	-648.67%	782.36%	-43.72%	-16.51%	61.50%	0.00%
EBIT Growth	62.38%	80.67%	-65,142.11%	97.64%	-166.03%	14.16%	28.10%	0.00%
NOPAT Growth	62.49%	81.28%	-4,412.18%	-139.67%	55.99%	21.97%	28.10%	0.00%
Net Income Growth	30.13%	76.99%	-1,364.03%	22.85%	-35.56%	-6.80%	8.25%	0.00%
EPS Growth	34.69%	76.44%	-922.95%	25.61%	12.77%	15.32%	9.02%	0.00%
Operating Cash Flow Growth	-13.11%	46.12%	57.29%	22.88%	124.10%	550.50%	-491.48%	0.00%
Free Cash Flow Firm Growth	23.02%	-76.16%	156.43%	50.86%	-7,908.13%	103.91%	0.00%	0.00%
Invested Capital Growth	-9.30%	-9.93%	-31.88%	37.36%	331.76%	-5.92%	0.00%	0.00%
Revenue Q/Q Growth	-0.80%	0.32%	4.50%	5.93%	19.05%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	284.33%	-99.32%	10.93%	4.18%	-58.53%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	72.82%	-284.07%	7.98%	-249.96%	-192.41%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	72.48%	-151.28%	6.80%	32.28%	56.03%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	50.60%	-455.80%	9.89%	-56.54%	25.30%	0.00%	0.00%	0.00%
EPS Q/Q Growth	51.52%	-625.00%	8.24%	-48.78%	38.35%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-7.12%	7.82%	30.36%	-26.57%	97.95%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	15.42%	-39.58%	216.95%	43.78%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-4.05%	-7.20%	2.76%	41.82%	230.58%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	66.00%	65.52%	64.13%	66.64%	65.01%	63.87%	55.57%	57.04%
EBITDA Margin	18.50%	0.29%	-112.49%	29.05%	4.93%	11.27%	13.58%	8.87%
Operating Margin	-10.78%	-27.95%	-147.59%	-4.64%	-2.89%	-8.47%	-10.92%	-16.02%
EBIT Margin	-10.58%	-27.34%	-139.82%	-0.30%	-19.25%	-9.31%	-10.92%	-16.02%
Profit (Net Income) Margin	-24.90%	-34.66%	-148.89%	-14.41%	-27.96%	-26.54%	-25.00%	-28.76%
Tax Burden Percent	114.97%	90.00%	99.28%	104.76%	99.24%	104.11%	102.39%	92.53%
Interest Burden Percent	204.81%	140.86%	107.27%	4,529.82%	146.35%	273.78%	223.74%	193.99%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.96%	-4.72%	-19.43%	-0.42%	-0.34%	-1.97%	-4.91%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-12.34%	-13.56%	-44.82%	-5.59%	-13.88%	-13.28%	-22.02%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-9.48%	-9.51%	-22.84%	-2.16%	-6.48%	-20.52%	-41.19%	0.00%
Return on Equity (ROE)	-11.44%	-14.23%	-42.27%	-2.58%	-6.82%	-22.50%	-46.10%	0.00%
Cash Return on Invested Capital (CROIC)	7.80%	5.73%	18.50%	-31.90%	-125.12%	4.13%	-204.91%	0.00%
Operating Return on Assets (OROA)	-2.24%	-5.39%	-21.79%	-0.03%	-2.60%	-2.42%	-2.85%	0.00%
Return on Assets (ROA)	-5.26%	-6.84%	-23.21%	-1.55%	-3.77%	-6.90%	-6.53%	0.00%
Return on Common Equity (ROCE)	-10.01%	-11.14%	-35.99%	-2.41%	-6.82%	-22.50%	-46.10%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-12.39%	-15.21%	-58.13%	-2.27%	-3.88%	-20.71%	-23.05%	0.00%
Net Operating Profit after Tax (NOPAT)	-193	-514	-2,748	-61	-25	-58	-74	-103
NOPAT Margin	-7.55%	-19.56%	-103.31%	-3.24%	-2.03%	-5.93%	-7.64%	-11.22%
Net Nonoperating Expense Percent (NNEP)	10.38%	8.84%	25.39%	5.17%	13.54%	11.31%	17.12%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-2.00%	-4.80%	-23.25%	-	-	-	-	-
Cost of Revenue to Revenue	34.00%	34.48%	35.87%	33.36%	34.99%	36.13%	44.43%	42.96%
SG&A Expenses to Revenue	28.46%	28.14%	27.44%	34.26%	43.43%	48.75%	42.65%	37.39%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	76.78%	93.47%	211.72%	71.28%	67.91%	72.34%	66.48%	73.06%
Earnings before Interest and Taxes (EBIT)	-270	-719	-3,719	-5.70	-241	-91	-106	-147
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	473	7.70	-2,992	545	62	110	132	81
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.70	1.34	1.04	1.43	1.99	4.11	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.41	2.34	2.11	8.02	14.36	5.26	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.84	1.15	1.02	1.27	1.73	2.36	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	3.06	4.52	4.39	11.37	16.92	6.87	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	16.56	1,544.28	0.00	39.13	343.32	60.93	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.11	15.98	22.90	65.90	80.52	56.89	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	10.21	19.06	4.46	0.00	0.00	55.35	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.88	0.79	0.73	0.46	0.39	1.31	1.89	0.00
Long-Term Debt to Equity	0.88	0.79	0.73	0.46	0.38	1.30	1.84	0.00
Financial Leverage	0.77	0.70	0.51	0.39	0.47	1.55	1.87	0.00
Leverage Ratio	2.17	2.08	1.82	1.67	1.81	3.26	3.53	0.00
Compound Leverage Factor	4.45	2.93	1.95	75.58	2.64	8.93	7.90	0.00
Debt to Total Capital	46.79%	44.07%	42.35%	31.51%	27.84%	56.74%	65.45%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.18%	0.23%	0.31%	1.98%	0.00%
Long-Term Debt to Total Capital	46.79%	44.07%	42.35%	31.34%	27.62%	56.43%	63.47%	0.00%
Preferred Equity to Total Capital	0.00%	13.00%	11.78%	8.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	53.21%	42.93%	45.86%	60.49%	72.16%	43.26%	34.55%	0.00%
Debt to EBITDA	9.55	613.13	-1.67	10.06	56.42	14.91	15.14	0.00
Net Debt to EBITDA	8.93	564.99	-1.55	8.98	52.01	14.22	14.94	0.00
Long-Term Debt to EBITDA	9.55	613.13	-1.67	10.01	55.95	14.83	14.68	0.00
Debt to NOPAT	-23.42	-9.18	-1.82	-90.10	-137.21	-28.36	-26.90	0.00
Net Debt to NOPAT	-21.89	-8.46	-1.69	-80.45	-126.49	-27.04	-26.55	0.00
Long-Term Debt to NOPAT	-23.42	-9.18	-1.82	-89.59	-136.08	-28.21	-26.09	0.00
Altman Z-Score	-0.43	-0.18	-0.80	1.06	1.77	1.01	0.00	0.00
Noncontrolling Interest Sharing Ratio	12.51%	21.75%	14.86%	6.64%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.87	0.91	0.89	0.86	0.81	0.76	0.63	0.00
Quick Ratio	0.76	0.80	0.79	0.70	0.70	0.63	0.55	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	767	624	2,617	-4,637	-9,437	121	-3,090	0.00
Operating Cash Flow to CapEx	223.66%	306.89%	251.01%	273.25%	244.66%	168.37%	-57.48%	17.64%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-18.37	-84.34	0.77	-23.62	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	1.28	2.35	0.75	-0.20	0.05
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.81	1.39	0.30	-0.55	-0.23
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.21	0.20	0.16	0.11	0.14	0.26	0.26	0.00
Accounts Receivable Turnover	3.00	2.95	2.99	2.28	2.34	2.93	2.92	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	48.65	49.55	38.46	31.26	46.18	50.38	46.92	0.00
Accounts Payable Turnover	6.47	7.38	8.27	5.93	8.09	10.85	11.20	0.00
Days Sales Outstanding (DSO)	121.82	123.60	122.03	159.87	155.94	124.59	124.86	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	56.40	49.43	44.11	61.57	45.12	33.64	32.59	0.00
Cash Conversion Cycle (CCC)	65.42	74.17	77.92	98.29	110.82	90.95	92.27	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	9,363	10,323	11,461	16,825	12,249	2,837	3,016	0.00
Invested Capital Turnover	0.26	0.24	0.19	0.13	0.17	0.33	0.64	0.00
Increase / (Decrease) in Invested Capital	-960	-1,138	-5,365	4,576	9,412	-179	3,016	0.00
Enterprise Value (EV)	7,832	11,891	11,664	21,339	21,217	6,690	0.00	0.00
Market Capitalization	3,609	6,148	5,623	15,048	18,003	5,128	0.00	0.00
Book Value per Share	$7.23	$6.93	$8.04	$16.46	$14.91	$4.09	$4.83	$0.00
Tangible Book Value per Share	($6.85)	($9.69)	($10.23)	($12.14)	($7.23)	($6.25)	($10.07)	$0.00
Total Capital	9,658	10,713	11,818	17,413	12,521	2,886	3,041	0.00
Total Debt	4,519	4,721	5,005	5,487	3,487	1,638	1,991	0.00
Total Long-Term Debt	4,519	4,721	5,005	5,456	3,458	1,629	1,930	0.00
Net Debt	4,224	4,350	4,648	4,899	3,214	1,561	1,965	0.00
Capital Expenditures (CapEx)	289	243	203	119	108	70	45	38
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-484	-509	-521	-822	-519	-225	-200	0.00
Debt-free Net Working Capital (DFNWC)	-189	-138	-165	-234	-247	-149	-175	0.00
Net Working Capital (NWC)	-189	-138	-165	-265	-276	-158	-235	0.00
Net Nonoperating Expense (NNE)	444	397	1,212	210	325	201	168	161
Net Nonoperating Obligations (NNO)	4,224	4,330	4,648	4,899	3,214	1,588	1,965	0.00
Total Depreciation and Amortization (D&A)	743	727	727	551	303	201	237	228
Debt-free, Cash-free Net Working Capital to Revenue	-18.93%	-19.34%	-19.60%	-43.79%	-41.41%	-23.10%	-20.69%	0.00%
Debt-free Net Working Capital to Revenue	-7.39%	-5.24%	-6.19%	-12.48%	-19.69%	-15.28%	-18.04%	0.00%
Net Working Capital to Revenue	-7.39%	-5.24%	-6.19%	-14.11%	-21.97%	-16.21%	-24.28%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.96)	($1.47)	$0.00	($0.49)	($0.25)	($0.77)	($147.14)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	693.60M	671.60M	0.00	630.98M	607.98M	361.66M	1.65M	0.00
Adjusted Diluted Earnings per Share	($0.96)	($1.47)	$0.00	($0.61)	($0.25)	($0.77)	($147.14)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	693.60M	671.60M	0.00	640.77M	607.98M	361.66M	1.65M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.25)	($0.77)	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	691.64M	666.29M	0.00	683.15M	428.60M	273.88M	217.47M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	199	200	413	30	14	-34	-74	-35
Normalized NOPAT Margin	7.79%	7.59%	15.53%	1.59%	1.11%	-3.48%	-7.64%	-3.87%
Pre Tax Income Margin	-21.66%	-38.52%	-149.98%	-13.76%	-28.17%	-25.50%	-24.42%	-31.08%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-0.02	-2.16	-0.58	-0.81	-1.06
NOPAT to Interest Expense	0.00	0.00	0.00	-0.24	-0.23	-0.37	-0.57	-0.74
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.49	-3.12	-1.02	-1.16	-1.34
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.71	-1.19	-0.81	-0.91	-1.02
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-5.92%	-8.29%	-1.90%	-6.99%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-37.33%	-19.26%	-6.32%	-65.92%	0.00%	-77.33%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Clarivate's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.43%	-3.03%	-3.86%	-2.77%	-1.26%	1.24%	1.81%	-2.59%	-5.00%	20.44%	43.79%
EBITDA Growth	-13.79%	121.48%	-27.92%	-154.19%	-15.96%	-216.31%	106.76%	-69.28%	-28.93%	245.88%	-1,884.26%
EBIT Growth	-303.92%	92.08%	-78.26%	-181.03%	-80.93%	-343.86%	102.31%	-163.17%	-63.18%	0.00%	-4,537.27%
NOPAT Growth	-516.00%	92.10%	-60.49%	-171.80%	-90.84%	-231.56%	101.26%	-183.77%	5.09%	1,778.16%	-24,139.21%
Net Income Growth	-38.53%	77.27%	-633.33%	-147.20%	-272.41%	-360.95%	100.28%	-297.28%	-37.41%	390.31%	-15,647.54%
EPS Growth	-7.14%	79.07%	-800.00%	-119.05%	-450.00%	-380.43%	99.85%	0.00%	166.67%	560.00%	-5,433.33%
Operating Cash Flow Growth	-2.84%	-25.98%	24.17%	-22.29%	-22.55%	39.44%	-21.37%	67.08%	237.54%	648.09%	374.43%
Free Cash Flow Firm Growth	-28.53%	56.35%	1,932.57%	-72.42%	-74.80%	-89.86%	102.89%	218.25%	217.69%	227.01%	71.13%
Invested Capital Growth	-9.44%	-9.30%	-12.28%	-13.02%	-11.49%	-9.93%	-0.26%	-29.77%	-31.22%	-31.88%	-6.00%
Revenue Q/Q Growth	-10.45%	6.56%	-4.32%	4.68%	-9.14%	5.64%	-3.23%	6.31%	-6.84%	6.23%	-7.41%
EBITDA Q/Q Growth	29.85%	-36.17%	485.69%	-126.97%	132.35%	-314.19%	189.97%	-58.17%	-55.23%	112.45%	-1,417.79%
EBIT Q/Q Growth	66.61%	-387.10%	109.04%	-2,452.94%	101.30%	-888.28%	216.86%	-259.63%	-83.42%	107.46%	-3,296.67%
NOPAT Q/Q Growth	66.61%	-387.10%	109.04%	-4,900.00%	100.63%	-1,535.22%	162.20%	-261.72%	-90.89%	113.69%	-4,250.80%
Net Income Q/Q Growth	45.83%	-192.38%	78.44%	-305.73%	91.11%	-6,960.98%	109.99%	-382.99%	-86.55%	107.32%	-7,176.12%
EPS Q/Q Growth	44.44%	-200.00%	80.43%	-228.57%	89.15%	-12,800.00%	95.24%	-625.00%	-91.30%	106.93%	0.00%
Operating Cash Flow Q/Q Growth	21.16%	-30.36%	60.78%	-28.38%	-7.70%	16.83%	0.62%	-28.62%	66.18%	-34.12%	113.79%
Free Cash Flow Firm Q/Q Growth	3.03%	-33.63%	5.55%	-0.98%	125.38%	762.87%	-98.57%	-9.52%	-9.34%	345.98%	41.40%
Invested Capital Q/Q Growth	-1.80%	-4.05%	-1.07%	-2.85%	-1.64%	-7.20%	-1.91%	-1.14%	0.09%	2.76%	-30.93%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	65.13%	65.66%	66.23%	67.15%	64.94%	66.08%	65.91%	66.48%	63.49%	64.90%	64.81%
EBITDA Margin	28.21%	19.46%	32.48%	-8.06%	31.28%	-87.85%	43.33%	14.46%	36.75%	76.47%	-652.57%
Operating Margin	-3.50%	-9.40%	3.49%	-36.91%	0.80%	-115.28%	13.47%	-13.20%	8.68%	47.16%	-688.25%
EBIT Margin	-3.50%	-9.40%	3.49%	-36.91%	1.64%	-115.07%	15.42%	-12.77%	8.50%	47.77%	-679.86%
Profit (Net Income) Margin	-17.50%	-28.93%	-10.54%	-46.79%	-12.07%	-123.43%	1.90%	-18.41%	6.91%	47.89%	-694.59%
Tax Burden Percent	122.09%	145.08%	129.90%	97.81%	125.00%	97.91%	44.09%	77.71%	-216.42%	131.68%	100.50%
Interest Burden Percent	409.13%	212.20%	-232.72%	129.63%	-588.24%	109.56%	27.96%	185.48%	-37.57%	76.13%	101.65%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	55.91%	0.00%	0.00%	-31.68%	0.00%
Return on Invested Capital (ROIC)	-0.64%	-1.71%	0.60%	-6.34%	0.14%	-19.48%	1.40%	-1.75%	1.13%	11.68%	-106.55%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.76%	-5.17%	-1.26%	-9.49%	-1.65%	-25.99%	0.85%	-3.04%	1.25%	9.67%	-151.27%
Return on Net Nonoperating Assets (RNNOA)	-2.13%	-3.98%	-0.90%	-6.55%	-1.13%	-18.22%	0.63%	-1.61%	0.63%	4.93%	-53.94%
Return on Equity (ROE)	-2.77%	-5.68%	-0.29%	-12.89%	-0.99%	-37.70%	2.03%	-3.36%	1.77%	16.61%	-160.49%
Cash Return on Invested Capital (CROIC)	7.73%	7.80%	6.37%	7.75%	7.11%	5.73%	9.27%	14.14%	17.51%	18.50%	-19.44%
Operating Return on Assets (OROA)	-0.74%	-1.99%	0.71%	-7.45%	0.33%	-22.70%	2.97%	-2.05%	1.33%	7.45%	-108.52%
Return on Assets (ROA)	-3.69%	-6.11%	-2.14%	-9.45%	-2.39%	-24.35%	0.37%	-2.95%	1.08%	7.46%	-110.87%
Return on Common Equity (ROCE)	-2.42%	-4.97%	-0.26%	-11.46%	-0.78%	-29.50%	1.59%	-2.84%	1.50%	14.14%	-134.14%
Return on Equity Simple (ROE_SIMPLE)	-13.24%	0.00%	-23.38%	-21.61%	-17.49%	0.00%	3.83%	-60.13%	-57.28%	0.00%	-72.35%
Net Operating Profit after Tax (NOPAT)	-15	-44	15	-168	3.50	-552	38	-62	38	419	-3,063
NOPAT Margin	-2.45%	-6.58%	2.44%	-25.83%	0.56%	-80.70%	5.94%	-9.24%	6.08%	62.10%	-481.77%
Net Nonoperating Expense Percent (NNEP)	2.12%	3.46%	1.86%	3.15%	1.79%	6.51%	0.55%	1.29%	-0.11%	2.01%	44.72%
Return On Investment Capital (ROIC_SIMPLE)	-0.15%	-0.45%	-	-	-	-5.15%	-	-	-	3.55%	-
Cost of Revenue to Revenue	34.87%	34.34%	33.77%	32.85%	35.06%	33.92%	34.09%	33.52%	36.51%	35.10%	35.19%
SG&A Expenses to Revenue	30.05%	27.27%	27.27%	28.48%	30.89%	26.34%	26.56%	28.84%	30.96%	26.74%	26.66%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	68.64%	75.05%	62.75%	104.06%	64.13%	181.37%	52.44%	79.68%	54.81%	17.74%	753.06%
Earnings before Interest and Taxes (EBIT)	-21	-62	22	-240	10	-787	100	-85	54	323	-4,322
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	168	129	202	-52	194	-601	280	97	231	516	-4,148
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.54	0.70	0.93	0.68	1.10	1.34	0.86	1.16	1.14	1.04	1.35
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.07	1.41	1.99	1.46	1.88	2.34	1.73	2.47	2.41	2.11	2.48
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	25.11	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.98%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.75	0.84	0.96	0.82	1.04	1.15	0.93	1.08	1.07	1.02	1.14
Enterprise Value to Revenue (EV/Rev)	2.72	3.06	3.64	3.10	4.05	4.52	3.97	4.70	4.66	4.39	5.00
Enterprise Value to EBITDA (EV/EBITDA)	15.43	16.56	0.00	0.00	0.00	1,544.28	9.24	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	26.61	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	10.36	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	10.73	12.11	13.48	12.28	15.30	15.98	15.05	16.68	18.28	22.90	32.60
Enterprise Value to Free Cash Flow (EV/FCFF)	9.21	10.21	14.12	9.82	13.79	19.06	10.07	6.31	4.97	4.46	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.90	0.88	0.84	0.83	0.79	0.79	0.73	0.70	0.70	0.73	0.90
Long-Term Debt to Equity	0.90	0.88	0.84	0.83	0.79	0.79	0.73	0.70	0.70	0.73	0.89
Financial Leverage	0.77	0.77	0.71	0.69	0.68	0.70	0.75	0.53	0.51	0.51	0.36
Leverage Ratio	2.20	2.17	2.09	2.06	2.06	2.08	2.13	1.81	1.80	1.82	1.88
Compound Leverage Factor	8.99	4.61	-4.86	2.66	-12.11	2.28	0.60	3.36	-0.68	1.39	1.91
Debt to Total Capital	47.35%	46.79%	45.66%	45.27%	44.06%	44.07%	42.14%	41.21%	41.25%	42.35%	47.40%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	0.00%	0.50%
Long-Term Debt to Total Capital	47.35%	46.79%	45.66%	45.27%	44.06%	44.07%	42.13%	41.20%	41.24%	42.35%	46.91%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	13.23%	13.00%	12.06%	11.80%	11.76%	11.78%	12.06%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	52.65%	53.21%	54.34%	54.73%	42.71%	42.93%	45.80%	46.99%	47.00%	45.86%	40.54%
Debt to EBITDA	10.13	9.55	-18.05	-26.00	-158.83	613.13	4.33	-1.47	-1.58	-1.67	-1.63
Net Debt to EBITDA	9.34	8.93	-16.54	-23.89	-146.44	564.99	3.97	-1.34	-1.46	-1.55	-1.49
Long-Term Debt to EBITDA	10.13	9.55	-18.05	-26.00	-158.83	613.13	4.33	-1.47	-1.58	-1.67	-1.61
Debt to NOPAT	-21.43	-23.42	-6.61	-7.07	-8.45	-9.18	4.85	-1.70	-1.78	-1.82	-1.86
Net Debt to NOPAT	-19.75	-21.89	-6.05	-6.50	-7.79	-8.46	4.45	-1.54	-1.65	-1.69	-1.70
Long-Term Debt to NOPAT	-21.43	-23.42	-6.61	-7.07	-8.45	-9.18	4.85	-1.70	-1.78	-1.82	-1.84
Altman Z-Score	-0.46	-0.37	-0.15	-0.33	-0.12	-0.19	0.01	0.14	0.17	0.16	-0.98
Noncontrolling Interest Sharing Ratio	12.76%	12.51%	11.42%	11.10%	21.68%	21.75%	21.83%	15.49%	14.92%	14.86%	16.42%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.88	0.87	0.88	0.90	0.86	0.91	0.94	0.95	0.90	0.89	0.89
Quick Ratio	0.77	0.76	0.76	0.79	0.73	0.80	0.79	0.81	0.75	0.79	0.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	944	917	1,381	1,308	1,321	586	68	4,745	5,244	5,784	-2,351
Operating Cash Flow to CapEx	281.12%	171.90%	264.88%	191.50%	273.60%	298.75%	264.83%	281.94%	383.64%	295.04%	308.31%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-32.89
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.91
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.96
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.21	0.21	0.20	0.20	0.20	0.20	0.19	0.16	0.16	0.16	0.16
Accounts Receivable Turnover	3.06	3.00	3.35	3.32	3.15	2.95	3.46	3.30	3.09	2.99	3.74
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	48.50	48.65	53.14	53.82	51.64	49.55	49.16	40.92	39.71	38.46	59.99
Accounts Payable Turnover	7.71	6.47	7.74	7.48	8.75	7.38	8.89	8.13	8.53	8.27	9.03
Days Sales Outstanding (DSO)	119.30	121.82	108.95	109.82	115.69	123.60	105.55	110.67	118.00	122.03	97.47
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	47.35	56.40	47.16	48.79	41.70	49.43	41.07	44.88	42.77	44.11	40.42
Cash Conversion Cycle (CCC)	71.96	65.42	61.79	61.03	73.99	74.17	64.48	65.80	75.23	77.92	57.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	9,194	9,363	9,758	9,864	10,153	10,323	11,123	11,340	11,471	11,461	11,153
Invested Capital Turnover	0.26	0.26	0.25	0.25	0.24	0.24	0.24	0.19	0.19	0.19	0.22
Increase / (Decrease) in Invested Capital	-959	-960	-1,366	-1,476	-1,318	-1,138	-30	-4,807	-5,206	-5,365	-711
Enterprise Value (EV)	6,885	7,832	9,385	8,061	10,602	11,891	10,390	12,254	12,237	11,664	12,737
Market Capitalization	2,718	3,609	5,141	3,802	4,933	6,148	4,538	6,440	6,333	5,623	6,324
Book Value per Share	$7.27	$7.23	$7.61	$8.39	$6.74	$6.93	$7.82	$8.21	$8.25	$8.04	$6.95
Tangible Book Value per Share	($7.06)	($6.85)	($6.84)	($7.34)	($9.60)	($9.69)	($9.66)	($9.67)	($9.97)	($10.23)	($10.94)
Total Capital	9,548	9,658	10,146	10,240	10,526	10,713	11,550	11,803	11,845	11,818	11,549
Total Debt	4,521	4,519	4,633	4,635	4,638	4,721	4,868	4,864	4,886	5,005	5,475
Total Long-Term Debt	4,521	4,519	4,633	4,635	4,638	4,721	4,866	4,863	4,885	5,005	5,417
Net Debt	4,167	4,224	4,244	4,259	4,276	4,350	4,460	4,421	4,512	4,648	5,020
Capital Expenditures (CapEx)	61	82	77	66	64	64	62	58	59	46	67
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-540	-484	-575	-527	-586	-509	-500	-522	-532	-521	-578
Debt-free Net Working Capital (DFNWC)	-186	-189	-187	-150	-224	-138	-93	-79	-157	-165	-123
Net Working Capital (NWC)	-186	-189	-187	-150	-224	-138	-94	-80	-158	-165	-181
Net Nonoperating Expense (NNE)	89	148	81	136	79	292	26	61	-5.28	96	1,353
Net Nonoperating Obligations (NNO)	4,167	4,224	4,244	4,259	4,265	4,330	4,441	4,402	4,512	4,648	5,078
Total Depreciation and Amortization (D&A)	188	191	180	188	184	186	181	182	178	194	174
Debt-free, Cash-free Net Working Capital to Revenue	-21.36%	-18.93%	-22.31%	-20.24%	-22.35%	-19.34%	-19.08%	-20.02%	-20.24%	-19.60%	-22.71%
Debt-free Net Working Capital to Revenue	-7.37%	-7.39%	-7.24%	-5.78%	-8.55%	-5.24%	-3.54%	-3.04%	-5.99%	-6.19%	-4.84%
Net Working Capital to Revenue	-7.37%	-7.39%	-7.24%	-5.78%	-8.55%	-5.24%	-3.58%	-3.08%	-6.03%	-6.19%	-7.10%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.15)	($0.27)	($0.09)	($0.46)	($0.14)	($1.29)	($0.01)	($0.21)	$0.04	$0.48	($6.58)
Adjusted Weighted Average Basic Shares Outstanding	689.80M	693.60M	718.70M	685.60M	666.90M	671.60M	670.90M	675.90M	674.80M	676.10M	673.55M
Adjusted Diluted Earnings per Share	($0.15)	($0.27)	($0.09)	($0.46)	($0.14)	($1.29)	($0.01)	($0.21)	$0.04	$0.46	($6.64)
Adjusted Weighted Average Diluted Shares Outstanding	689.80M	693.60M	718.70M	685.60M	666.90M	671.60M	670.90M	675.90M	679.30M	678.60M	675.18M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	683.09M	691.64M	710.40M	724.14M	668.24M	666.29M	663.92M	676.23M	675.76M	674.43M	674.19M
Normalized Net Operating Profit after Tax (NOPAT)	2.73	117	28	44	10	50	64	41	45	270	70
Normalized NOPAT Margin	0.46%	17.65%	4.44%	6.84%	1.63%	7.29%	9.83%	6.19%	7.12%	39.98%	10.95%
Pre Tax Income Margin	-14.33%	-19.94%	-8.12%	-47.84%	-9.66%	-126.06%	4.31%	-23.68%	-3.20%	36.37%	-691.11%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-60.45
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-42.83
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-61.39
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-43.78
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-2.82%	-5.92%	-4.38%	-6.24%	-7.33%	-8.29%	29.48%	-1.81%	-1.89%	-1.90%	-1.72%
Augmented Payout Ratio	-40.38%	-37.33%	-12.14%	-6.24%	-7.33%	-19.26%	68.53%	-1.81%	-1.89%	-6.32%	-7.84%

Frequently Asked Questions About Clarivate's Financials

When does Clarivate's fiscal year end?

According to the most recent income statement we have on file, Clarivate's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Clarivate's net income changed over the last 7 years?

Clarivate's net income appears to be on an upward trend, with a most recent value of -$636.70 million in 2024, rising from -$263.93 million in 2017. The previous period was -$911.20 million in 2023. See Clarivate's forecast for analyst expectations on what’s next for the company.

What is Clarivate's operating income?

Clarivate's total operating income in 2024 was -$275.60 million, based on the following breakdown:

Total Gross Profit: $1.69 billion
Total Operating Expenses: $1.96 billion

How has Clarivate revenue changed over the last 7 years?

Over the last 7 years, Clarivate's total revenue changed from $917.63 million in 2017 to $2.56 billion in 2024, a change of 178.6%.

How much debt does Clarivate have?

Clarivate's total liabilities were at $6.35 billion at the end of 2024, a 5.4% decrease from 2023, and a 138.9% increase since 2018.

How much cash does Clarivate have?

In the past 6 years, Clarivate's cash and equivalents has ranged from $25.58 million in 2018 to $430.90 million in 2021, and is currently $295.20 million as of their latest financial filing in 2024.

How has Clarivate's book value per share changed over the last 7 years?

Over the last 7 years, Clarivate's book value per share changed from 0.00 in 2017 to 7.23 in 2024, a change of 723.4%.

Related Companies

This page (NYSE:CLVT) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clarivate (CLVT) Financials

Frequently Asked Questions About Clarivate's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clarivate (CLVT) Financials

Annual Income Statements for Clarivate

Quarterly Income Statements for Clarivate

Annual Cash Flow Statements for Clarivate

Quarterly Cash Flow Statements for Clarivate

Annual Balance Sheets for Clarivate

Quarterly Balance Sheets for Clarivate

Annual Metrics And Ratios for Clarivate

Quarterly Metrics And Ratios for Clarivate

Frequently Asked Questions About Clarivate's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools